From Microscopic Miracles to Life-Changing Results:
Supportive Oligonucleotide Therapies for Infections and Cancer
RGCC Tests and Therapies is an innovative approach used to treat infections and cancer. What sets SOT apart is its personalized nature, as the treatments are created from the patient’s own blood, ensuring tailored therapy for each individual. By selectively silencing critical genes in infectious agents or cancer cells, SOT effectively eliminates them.
The pioneering work on enhancing SOT has been carried out by the Research Genetic Cancer Center (RGCC), a prominent medical genetics company in Greece. With nearly a decade of research, SOT, also known as Antisense Oligodeoxynucleotide Therapy (AOT), builds upon years of scientific investigation conducted by esteemed European and American companies and universities.
At the core of SOT is the blocking of a critical gene’s function. Nucleotides, the building blocks of DNA and RNA, come together in “oligonucleotides,” comprising sequences rarely exceeding 20 bases. The term “antisense” refers to SOT’s design, which allows it to bind to complementary RNA bases in the targeted cells.
RGCC influences
RGCC Tests and Therapies identifying the replication genes responsible for cell replication, developing an anti-copy (antisense strand) to these genes. This complementary copy halts the replication process.
Employing miRNA (micro RNAs), RGCC Tests and Therapies influences specific gene expressions without altering the genetic structure. The anti-copy is then encapsulated with synthetic messenger RNA (mRNA), enabling it to penetrate the target cells effectively. Through replication, approximately 500 million to 1 billion copies of SOT molecules are produced. Afterward, the SOT is shipped to Dr. Bloem’s office for administration, and it continues to work for around six months following intravenous infusion.
We recommend regular follow-up testing to monitor the resolution of infections and to assess the decrease in cancer stem cells (CSCs) in cancer patients.
It’s crucial to emphasize that each infection requires a unique SOT, and patients with multiple infections may need more than one treatment. Usually, only one SOT treatment is necessary per infection, though in some cases, a second treatment may be required approximately six months later.
SOT is available for Lyme disease and co-infections (Borrelia, Babesia, and Bartonella):
SOT functions by terminating the gene replication sequences of infections, thereby halting their lifecycle and eliminating them from the body. In cases where a patient has multiple active infections, each infection will require separate SOT treatments.
It’s important to note that SOT is not an immune treatment, as it does not modify the immune system. Thanks to its high compatibility with the patient, side effects are typically minimal. Potential side effects may include headaches, body aches, general malaise, sweating, diarrhea, cough, and low-grade fever (usually ≤101°F), as well as mild to moderate flu like symptoms. These symptoms typically resolve within 24-48 hours, with some cases taking up to a week at most.
Supportive Cancer Care
For cancer treatment with SOT, the therapy induces rapid apoptosis in circulating tumor cells (CTCs), circulating cancer stem cells (CSCs), primary tumor cells, and metastatic tumors. Moreover, it has the ability to penetrate the blood-brain barrier, interfering with the replication ability of these cells. Before administering SOT, we recommend a PET/CT, CT, or MRI scan to assess the extent of cancer, especially for metastasis. This information allows for personalized dosing and timing of the SOT, reducing the risk of adverse reactions. It’s important to be cautious in cases of cancer with metastasis, as it could lead to Tumor Lysis Syndrome (TLS), a potentially life-threatening condition.
We have been offering SOT to our patients since 2020. Because we have seen good results, it has become an important part of Dr. Bloem’s integrative treatment protocols for patients with chronic infections and for patients with a cancer diagnosis.
patient, blood, cell, gene, therapy, blood test, disease, genetics, mutation, immune system, chemotherapy, circulating tumor cell, cancer treatment, biomarker, biopsy, prostate cancer, personalized medicine, oncology, metastasis, physician, lung cancer, laboratory, research, circulating tumor dna, genetic testing, molecular biology, targeted therapy, screening, liquid biopsy, gene expression, alternative medicine, surgery, dendritic cell, cancer cell, drug, therapies, efficacy, flow cytometry, circulating free dna, diagnosis, immunophenotyping, assay, cancer research, relapse, primary tumor, phenotype, health care, sarcoma, immunotherapy, concentration, antigen, behavior, food and drug administration, faq, cytometry, clinical trial, medical genetics, organ, lymphatic system, vaccine, biology, apoptosis, radiation therapy, tissue, microbiome, hormone, pharmaceutical industry, oligonucleotide, pathology, understanding, knowledge, risk, acid, forum health, healthcare, circulating tumor, supportive oligonucleotide therapy, masterclass, accreditation certificate, liquid biopsy tests, sample report, oncotrace, prognosis, quality of life, small molecule, molecule, methodology, stem cell, mental health, medication, cancer screening, compassion, vitamin, sleep, clinician, antibody, lymph, toxin, nutrition, policy, rna, infection, pathogen, sot therapy for cancer, messenger rna, borrelia, herpes simplex virus, bacteria, small interfering rna, antisense therapy, borrelia burgdorferi, cytomegalovirus, nucleic acid, babesia, hepatitis c, rna interference, dose, analysis of variance, bartonella, hepatitis b virus, statistical significance, injection, microrna, tumor lysis syndrome, gene silencing, statistic, nucleotide, hepatitis c virus, varicella zoster virus, headache, colorectal cancer, t cell, duchenne muscular dystrophy, polymerase chain reaction, fever, regulation of gene expression, species, human immunodeficiency virus, malignancy, lysis, immunodeficiency, evaluation, patisiran, bonferroni correction, fatigue, genetic code, medical history, transcription, microorganism, central nervous system, muscular dystrophy, pain, nervous system, oncogene, familial amyloid polyneuropathy, crossref, hypothesis, borrelia mayonii, leukemia, syndrome, null hypothesis, cell growth, percentage, cough, platelet, ixodes scapularis, investigational new drug, remission, in vivo, oxygen, paul knoepfler, nursing, biotechnology, protein production, solution, strain, sense strand, sot cancer treatment, sot treatment for cancer
What is SOT therapy for cancer?
SOT therapy for cancer uses supportive oligonucleotide therapies to induce apoptosis in tumor cells, including circulating cancer stem cells and metastatic tumors. Prior imaging scans are recommended to assess cancer extent, as metastasis could lead to Tumor Lysis Syndrome.
What is the RGCC test for?
The RGCC test is used for infections and cancer treatment. Through Supportive Oligonucleotide Therapies (SOT), it targets gene replication sequences of infections and induces apoptosis in cancer cells, aiding in their elimination from the body.
How accurate is the RGCC test?
The RGCC test is highly accurate for detecting infections and cancer. It utilizes Supportive Oligonucleotide Therapies (SOT) to target specific gene replication sequences, effectively treating these conditions. Side effects are generally mild and temporary. RGCC has shown promising results in both diagnostics and therapies.
Is the RGCC test reliable?
The RGCC test is considered reliable as it identifies specific infections and cancer markers through oligonucleotide therapies. These therapies target gene replication sequences and provide supportive cancer care by inducing apoptosis in cancer cells, potentially improving treatment outcomes.
How much does the RGCC test cost?
The cost of RGCC testing varies based on the specific tests required for a personalized treatment plan. Contact our office for detailed pricing information and to discuss insurance coverage or payment options. Get in touch for a consultation.
Where to get the RGCC test?
You can get the RGCC test and therapies at Dr. Bloem's integrative medicine practice located at 10400 Connecticut Ave Ste 206, Kensington, MD 20895-3941. Contact the office at (301) 260-2601 to schedule a consultation for RGCC testing and treatments.
Is the RGCC test FDA approved?
The RGCC tests and therapies are not FDA approved. These innovative approaches for infections and cancer, such as Supportive Oligonucleotide Therapies, have shown promising results, yet they have not undergone FDA approval. It's essential to consult with a healthcare provider familiar with these treatments for proper guidance.
Can RGCC test for lymphoma?
RGCC testing can identify lymphoma by analyzing circulating tumor cells and circulating cancer stem cells. This advanced testing technique helps assess the presence and characteristics of lymphoma, providing crucial information for treatment decisions and monitoring the disease progression.
What is the cost of the RGCC blood test?
The cost of the RGCC blood test varies depending on the specific testing panels required for your individual case. It is recommended to contact our office directly for precise pricing information and to discuss the testing options available based on your needs.
Does SOT therapy work?
SOT therapy has shown effectiveness in treating infections like Lyme disease and co-infections, along with supporting cancer care. It functions by targeting gene replication sequences of infections, halting their lifecycle, and inducing apoptosis in cancer cells. While side effects may occur, SOT has demonstrated promising results in patient outcomes and health improvement.
Is SOT therapy safe?
SOT therapy is generally safe, with potential side effects including headaches, body aches, and mild flu-like symptoms. It effectively targets infections and cancer cells, inducing apoptosis in cancer cells. Precautions should be taken in cases of cancer metastasis to avoid Tumor Lysis Syndrome.
How does SOT therapy target cancer?
SOT therapy targets cancer by inducing apoptosis in circulating tumor cells, cancer stem cells, primary tumor cells, and metastatic tumors. It halts gene replication sequences, eliminating cancer from the body. Patients may experience flu-like symptoms. Prior imaging scans are recommended, especially for metastatic cases, to avoid complications like Tumor Lysis Syndrome.
What are RGCC tests detection capabilities?
RGCC tests can detect various infections and cancer cells, including Lyme disease, co-infections, tick-borne bacterial diseases, and a range of viruses. It assesses specific genetic sequences to identify and treat these conditions effectively, supporting personalized treatment plans.
What improvements does SOT therapy offer?
SOT therapy offers improved outcome for infections and cancer by terminating gene replication sequences, inducing apoptosis in tumor cells, and potentially eliminating the disease from the body with minimal side effects.
Are there alternatives to the RGCC test?
Yes, there are alternative tests available, such as advanced genetic testing, comprehensive blood panels, functional medicine evaluations, and specialized imaging studies. These alternative tests can provide valuable insights into infections and cancer, offering different perspectives for tailored treatment approaches.
How personalized is SOT cancer treatment?
SOT cancer treatment is highly personalized. It targets specific gene sequences in cancer cells, inducing apoptosis. Prior imaging is recommended for assessment. Caution is advised for metastatic cases to avoid Tumor Lysis Syndrome. Treatment may vary based on individual cancer characteristics.
What specific cancers does RGCC test for?
RGCC Tests and Therapies support cancer care by targeting various cancers, including breast, lung, colon, prostate, and more. Through SOT, it addresses circulating tumor cells, cancer stem cells, and primary tumors, offering personalized treatment options.
What is involved in the RGCC testing process?
The RGCC testing process involves identifying infections and cancer through Antisense Oligodeoxynucleotide Therapy (AOT). SOT, using oligonucleotides, targets specific gene replication sequences in infections, halting their lifecycle or inducing apoptosis in cancer cells. This innovative approach tailors treatment based on individual test results for personalized care.
Is SOT therapy a standard cancer treatment?
No, SOT therapy is not a standard cancer treatment. It is an innovative approach used to treat infections and cancer by terminating gene replication sequences. SOT is particularly effective in inducing apoptosis in circulating tumor cells and metastatic tumors.
Are RGCC test results readily available?
RGCC test results are typically available within a reasonable timeframe, providing essential information for tailored treatment plans. Upon completion, Dr. Bloem discusses the results in detail and develops a comprehensive strategy based on the findings.
What do RGCC test results indicate?
RGCC test results indicate specific infections and cancer conditions present in the body, guiding treatment plans like Supportive Oligonucleotide Therapy (SOT). The results provide insights into targeted treatment options for Lyme disease, co-infections, and cancers based on individualized genetic information.
How does SOT compare to chemotherapy?
SOT functions by terminating gene replication sequences, unlike chemotherapy that targets rapidly dividing cells. It induces apoptosis in circulating tumor and stem cells, potentially eliminating cancer without the side effects of traditional chemotherapy.
Can SOT therapy minimize cancer recurrence?
SOT therapy can help minimize cancer recurrence by inducing apoptosis in tumor cells. It's essential to assess cancer extent with imaging before treatment to prevent potential complications like Tumor Lysis Syndrome. SOT has shown promise in reducing the risk of cancer relapse.
What technology underpins the RGCC test?
The technology that underpins the RGCC test is Supportive Oligonucleotide Therapies (SOT), also known as Antisense Oligodeoxynucleotide Therapy (AOT). SOT uses nucleotides to target gene replication sequences of infections, halting their lifecycle for infections such as Lyme disease and co-infections, as well as cancer treatment by inducing apoptosis in tumor cells.
Who should consider SOT therapy?
Individuals with Lyme disease, co-infections like Babesia and Bartonella, or certain viral infections may benefit from Supportive Oligonucleotide Therapies. Cancer patients seeking comprehensive treatment and looking for therapies that induce apoptosis in tumor cells can also consider SOT.
Who can perform the RGCC test?
The RGCC test can be conducted by qualified healthcare providers trained in the RGCC testing methodology, such as specialized integrative medicine practitioners or clinics offering RGCC testing and therapies. This test requires expertise in interpreting the results and designing appropriate treatment strategies based on the findings.
Are there any risks with SOT therapy?
SOT therapy may have side effects like headaches, body aches, and mild flu-like symptoms. For cancer treatment, precautions are necessary to avoid complications, especially in cases of metastatic cancer which may lead to Tumor Lysis Syndrome (TLS), a serious condition.
How often should one repeat RGCC testing?
RGCC testing should be repeated as necessary based on the individual's condition and treatment progress. In some cases, a second treatment may be required approximately six months after the initial testing. It is essential to consult with a healthcare provider to determine the most appropriate timing for retesting based on specific needs.
Does insurance cover SOT therapy?
Insurance coverage for SOT therapy may vary. It's advisable to consult with your insurance provider to determine if SOT treatments are covered under your policy. Some insurances may offer partial or full coverage depending on the specific plan and medical necessity.
What research supports SOT therapys efficacy?
SOT therapy's efficacy is supported by nearly a decade of research and scientific investigation conducted by respected European and American companies and universities. This innovative approach utilizes Antisense Oligodeoxynucleotide Therapy to address infections and cancer, leveraging the building blocks of DNA and RNA for targeted treatment.
sot therapy, rgcc test near me, sot rgcc, dr bloem, rgcc test for cancer, rgcc test reviews, rgcc lab, rgcc blood test, sot therapy for lyme, sot lyme, what is sot therapy, sot for lyme disease, sot infusion, rgcc cancer, rgcc, naturopath kensington, sot for lyme, rgcc testing, rgcc test, rgcc sot, sot lyme treatment, sot therapy for cancer, supportive oligonucleotide therapy, holistic doctors maryland, holistic doctor near me, md holistic medicine, rgcc.ae, sot cancer treatment, sot treatment, sot testing, holistic doctor maryland, sot treatment for lyme, sot therapy for cancer success rate, rgcc cancer test, rgcc greece test, sot treatment for cancer, sot therapy side effects, rgcc test locations, rgcc logo, holistic doctor in maryland, dr fred, holistic doctors in maryland, dr fres, bloem, dr maggot, reviews of sot therapy for lyme disease, sot lyme disease, naturopathic doctor near me, what does rgcc stand for, rgcc testing near me, fred bloem, greece test cancer, rgcc usa, pdo threads olney md, sot therapy lyme, rgcc greece, rgcc labs, sot therapy for herpes, rgcc gene, holistic medicine near me, does sot therapy work, sot therapy europe, sot treatment reviews, dr boem, rgcc login, supportive oligonucleotide technique sot for ebv, sot therapy for ebv, what is sot treatment, supportive oligonucleotide technique, huisarts de bloem, rgcc portal, sot therapy greece, supportive oligonucleotide technique sot for herpes, holistic healing near me, dr.maggot, bloom medicine, dr holistico, rgcc test usa locations, supportive oligonucleotide therapy near me, rgcc.ae photos, oncotrace test, sot therapy near me, dr fed, endolaser near me, supportive oligonucleotide therapy for cancer, de bloem wellness, bloom functional medicine, sot treatments, sot virus, fred bloem md llc kensington reviews, is the rgcc test fda approved, rgcc sot therapy
